• Chandrasekar Palaniswamy, Aaron Mishkin, Wilbert S Aronow, Ankur Kalra, and William H Frishman.
• Department of Medicine, Division of Cardiology, New York Medical College/Westchester Medical Center, Valhalla 10595, NY, USA. drpchandrasekar@gmail.com
• Cardiol Rev. 2013 May 1; 21 (3): 141-50.

AbstractHeart failure (HF) poses a significant economic burden on our health-care resources with very high readmission rates. Remote monitoring has a substantial potential to improve the management and outcome of patients with HF. Readmission for decompensated HF is often preceded by a stage of subclinical hemodynamic decompensation, where therapeutic interventions would prevent subsequent clinical decompensation and hospitalization. Various methods of remote patient monitoring include structured telephone support, advanced telemonitoring technologies, remote monitoring of patients with implanted cardiac devices such as pacemakers and defibrillators, and implantable hemodynamic monitors. Current data examining the efficacy of remote monitoring technologies in improving outcomes have shown inconsistent results. Various medicolegal and financial issues need to be addressed before widespread implementation of this exciting technology can take place.

31 keywords...

hide…